Resources | Press Releases |Press Release

Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host a conference call on Tuesday, March 23, 2010 at 9:00 a.m. EST to review the Company’s fourth quarter and year-end December 31, 2009 financial results and provide an update on recent corporate developments. The Company will issue a press release regarding its financial results on the same day, prior to the conference call.

Webcast Information

To access the conference call, please dial 877-407-8031 (domestic) or 201-689-8031 (international). A replay of the call will be available from 11:00 a.m. Eastern Time on March 23rd until April 23, 2010 at midnight. To access the replay, please dial 877-660-6853 (domestic) or 201-612-7415 (international) and reference the account # 286 and the conference id # 346800. A live audio webcast of the call and the archived webcast will be available in the News and Events section of the Inhibitex website at http://www.inhibitex.com.

About Inhibitex

Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company focused on developing products to treat serious infectious diseases. The Company’s pipeline includes FV-100, which is in Phase II clinical development for the treatment of shingles, and INX-189, a nucleotide polymerase inhibitor for the treatment of chronic hepatitis C infections. The Company also has additional HCV nucleotide polymerase inhibitors in preclinical development and has licensed the use of its proprietary MSCRAMM® protein platform to Pfizer for the development of staphylococcal vaccines. For additional information about the Company, please visit www.inhibitex.com.

For additional information about the Company, please visit www.inhibitex.com.